| # | Title | Journal | Year | Citations |
|---|
| 1 | Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure<SUBTITLE>The EVEREST Outcome Trial</SUBTITLE> | JAMA - Journal of the American Medical Association | 2007 | 1,406 |
| 2 | Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy | New England Journal of Medicine | 2003 | 1,217 |
| 3 | Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction | Circulation | 2006 | 830 |
| 4 | Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets | Nature | 1992 | 771 |
| 5 | Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community | Journal of the American College of Cardiology | 2003 | 750 |
| 6 | Long-Term Effects of Surgical Septal Myectomy on Survival in Patients With Obstructive Hypertrophic Cardiomyopathy | Journal of the American College of Cardiology | 2005 | 677 |
| 7 | Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction | Journal of the American College of Cardiology | 2001 | 638 |
| 8 | Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance | Journal of the American College of Cardiology | 2008 | 604 |
| 9 | Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status | Journal of the American College of Cardiology | 2003 | 458 |
| 10 | Anemia as a risk factor for cardiovascular disease in the atherosclerosis risk in communities (aric) study | Journal of the American College of Cardiology | 2002 | 435 |
| 11 | A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes | Journal of the American College of Cardiology | 2003 | 363 |
| 12 | Cardiovascular Thrombotic Events in Controlled, Clinical Trials of Rofecoxib | Circulation | 2001 | 353 |
| 13 | Gender-Related Differences in the Clinical Presentation and Outcome of Hypertrophic Cardiomyopathy | Journal of the American College of Cardiology | 2005 | 342 |
| 14 | Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the Endothelin A Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial | Lancet, The | 2004 | 315 |
| 15 | The Framingham Predictive Instrument in Chronic Kidney Disease | Journal of the American College of Cardiology | 2007 | 285 |
| 16 | Cardiovascular risk factors and confounders among nondrinking and moderate-drinking U.S. adults | American Journal of Preventive Medicine | 2005 | 273 |
| 17 | Assessment and Significance of Left Ventricular Mass by Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy | Journal of the American College of Cardiology | 2008 | 269 |
| 18 | Adverse Cardiovascular Events Temporally Associated With Ma Huang, an Herbal Source of Ephedrine | Mayo Clinic Proceedings | 2002 | 248 |
| 19 | Mechanism of platelet inhibition by nitric oxide: In vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase | Proceedings of the National Academy of Sciences of the United States of America | 1998 | 244 |
| 20 | Kidney disease as a risk factor for recurrent cardiovascular disease and mortality | American Journal of Kidney Diseases | 2004 | 243 |
| 21 | Improving Survival From Sudden Cardiac Arrest | JAMA - Journal of the American Medical Association | 2001 | 242 |
| 22 | Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials | American Journal of Kidney Diseases | 2004 | 232 |
| 23 | Waist-to-Hip Ratio, Body Mass Index, and Subsequent Kidney Disease and Death | American Journal of Kidney Diseases | 2008 | 224 |
| 24 | Right Ventricular Involvement in Hypertrophic Cardiomyopathy | American Journal of Cardiology | 2007 | 179 |
| 25 | Hormone Replacement Therapy and the Cardiovascular System | Journal of the American College of Cardiology | 2006 | 177 |
| 26 | Rationale and Design of the Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) | Journal of Cardiac Failure | 2005 | 168 |
| 27 | Sex differences in mechanisms of arterial stiffness | British Journal of Pharmacology | 2019 | 163 |
| 28 | Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry | Journal of the American College of Cardiology | 2019 | 152 |
| 29 | Multicenter, Randomized, Double-Blind, Placebo-Controlled Study on the Effect of Oral Tolvaptan on Left Ventricular Dilation and Function in Patients With Heart Failure and Systolic Dysfunction | Journal of the American College of Cardiology | 2007 | 151 |
| 30 | Antifibrinolytic activity of apolipoprotein(a) in vivo: Human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis | Nature Medicine | 1995 | 150 |
| 31 | Voluntary electronic reporting of medical errors and adverse events | Journal of General Internal Medicine | 2006 | 150 |
| 32 | Clinical Utility of Endothelial Function Testing | Circulation | 2003 | 139 |
| 33 | Ventricular remodeling in a mouse model of myocardial infarction | American Journal of Physiology - Heart and Circulatory Physiology | 1998 | 135 |
| 34 | The Relationship Between Nontraditional Risk Factors and Outcomes in Individuals With Stage 3 to 4 CKD | American Journal of Kidney Diseases | 2008 | 131 |
| 35 | Significance of Papillary Muscle Abnormalities Identified by Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy | American Journal of Cardiology | 2008 | 130 |
| 36 | Randomized, Controlled Evaluation of Short- and Long-Term Benefits of Heart Failure Disease Management Within a Diverse Provider Network | Circulation | 2004 | 129 |
| 37 | Percutaneous mitral valve repair: A feasibility study in an ovine model of acute ischemic mitral regurgitation | Catheterization and Cardiovascular Interventions | 2003 | 120 |
| 38 | Arrhythmogenic right ventricular dysplasia: clinical results with implantable cardioverter defibrillators | Journal of Interventional Cardiac Electrophysiology | 1997 | 119 |
| 39 | Risk of adverse events with fibrates* | American Journal of Cardiology | 2004 | 119 |
| 40 | Clinical efficacy and safety of statins in managing cardiovascular risk | Vascular Health and Risk Management | 2008 | 106 |
| 41 | What Is the Best Approach for the Assessment of Left Atrial Size? Comparison of Various Unidimensional and Two-dimensional Parameters with Three-dimensional Echocardiographically Determined Left Atrial Volume | Journal of the American Society of Echocardiography | 2006 | 99 |
| 42 | Progress in Heart Failure Management? | Circulation | 2000 | 97 |
| 43 | Voluntary Electronic Reporting of Medical Errors and Adverse Events. An Analysis of 92,547 Reports from 26 Acute Care Hospitals | Journal of General Internal Medicine | 2006 | 90 |
| 44 | Enhanced Visualization of Intravascular and Left Atrial Appendage Thrombus with the Use of a Thrombus-Targeting Ultrasonographic Contrast Agent (MRX-408A1): In Vivo Experimental Echocardiographic Studies | Journal of the American Society of Echocardiography | 1999 | 87 |
| 45 | Randomized, Controlled Dose-Ranging Study of the Selective Adenosine A 2A Receptor Agonist Binodenoson for Pharmacological Stress as an Adjunct to Myocardial Perfusion Imaging | Circulation | 2004 | 83 |
| 46 | Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction | Journal of Cardiac Failure | 2002 | 82 |
| 47 | Commotio Cordis?Sudden Cardiac Death with Chest Wall Impact | Journal of Cardiovascular Electrophysiology | 2007 | 82 |
| 48 | Failure of Commercially Available Chest Wall Protectors to Prevent Sudden Cardiac Death Induced by Chest Wall Blows in an Experimental Model of Commotio Cordis | Pediatrics | 2006 | 80 |
| 49 | High Incidence of Appropriate Implantable Cardioverter-Defibrillator Therapy in Patients With Syncope of Unknown Etiology and Inducible Ventricular Arrhythmias | Journal of the American College of Cardiology | 1997 | 75 |
| 50 | Role of Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy | Circulation | 2004 | 74 |
